{
  "retracted": false,
  "timestamp": 1510876800000,
  "updates": [
    {
      "timestamp": 1585483992651,
      "identifier": {
        "doi": "10.1007/s12185-017-2369-z"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s12185-017-2265-6"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations"
}
